Literature DB >> 34905173

Development of a Standardized MRM Method for the Quantification of One Carbon Metabolism Enzymes.

Laura Guerrero1, Alberto Paradela1, Fernando J Corrales2,3.   

Abstract

One-carbon metabolism (1CM) plays a central role in liver physiology, being the source of essential metabolites such as S-adenosylmethionine, the main alkylating agent in living cells, and glutathione, their most important nonenzymatic antioxidant defense. Impairment of 1CM in hepatocytes is a recognized factor associated to chronic liver disorders and hepatocellular carcinoma. With this in mind, we have proposed the concept of functional biomarker referring to a cellular pathway that can be systematically monitored as indicative of a particular physiological or pathological condition. Here we describe a targeted mass spectrometry (MRM) protocol to simultaneously quantify 13 1CM enzymes in liver tissue specimens.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Hepatocellular carcinoma; Liver diseases; Mass spectrometry; Multiple reaction monitoring; One-carbon metabolism; Targeted proteomics

Mesh:

Substances:

Year:  2022        PMID: 34905173     DOI: 10.1007/978-1-0716-1936-0_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

Review 1.  Biomarkers in cancer staging, prognosis and treatment selection.

Authors:  Joseph A Ludwig; John N Weinstein
Journal:  Nat Rev Cancer       Date:  2005-11       Impact factor: 60.716

Review 2.  Mining the plasma proteome for cancer biomarkers.

Authors:  Samir M Hanash; Sharon J Pitteri; Vitor M Faca
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

Review 3.  Burden of liver diseases in the world.

Authors:  Sumeet K Asrani; Harshad Devarbhavi; John Eaton; Patrick S Kamath
Journal:  J Hepatol       Date:  2018-09-26       Impact factor: 25.083

4.  Prioritizing Popular Proteins in Liver Cancer: Remodelling One-Carbon Metabolism.

Authors:  María Isabel Mora; Manuela Molina; Leticia Odriozola; Félix Elortza; José María Mato; Barbara Sitek; Pumin Zhang; Fuchu He; María Uxue Latasa; Matías Antonio Ávila; Fernando José Corrales
Journal:  J Proteome Res       Date:  2017-10-02       Impact factor: 4.466

Review 5.  Serine, glycine and one-carbon units: cancer metabolism in full circle.

Authors:  Jason W Locasale
Journal:  Nat Rev Cancer       Date:  2013-07-04       Impact factor: 60.716

6.  Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.

Authors:  A Blythe Ryerson; Christie R Eheman; Sean F Altekruse; John W Ward; Ahmedin Jemal; Recinda L Sherman; S Jane Henley; Deborah Holtzman; Andrew Lake; Anne-Michelle Noone; Robert N Anderson; Jiemin Ma; Kathleen N Ly; Kathleen A Cronin; Lynne Penberthy; Betsy A Kohler
Journal:  Cancer       Date:  2016-03-09       Impact factor: 6.860

Review 7.  Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection.

Authors:  Shu-Chun Chuang; Carlo La Vecchia; Paolo Boffetta
Journal:  Cancer Lett       Date:  2008-12-16       Impact factor: 8.679

8.  Metabolic Remodeling during Liver Regeneration.

Authors:  Matias J Caldez; Noémi Van Hul; Hiromi W L Koh; Xing Qi Teo; Jun Jun Fan; Peck Yean Tan; Matthew R Dewhurst; Peh Gek Too; S Zakiah A Talib; Beatrice E Chiang; Walter Stünkel; Hanry Yu; Philip Lee; Tobias Fuhrer; Hyungwon Choi; Mikael Björklund; Philipp Kaldis
Journal:  Dev Cell       Date:  2018-10-18       Impact factor: 12.270

Review 9.  Epidemiology and surveillance for hepatocellular carcinoma: New trends.

Authors:  Amit G Singal; Pietro Lampertico; Pierre Nahon
Journal:  J Hepatol       Date:  2020-02       Impact factor: 25.083

Review 10.  Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma.

Authors:  Archana Rastogi
Journal:  World J Gastroenterol       Date:  2018-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.